Coya Therapeutics Inc: On May 22, Chardan Capital Markets Agreed To End Restricted Period With Respect To Certain Shares Subject To Lock-Up Agreements
Portfolio Pulse from Bill Haddad
Chardan Capital Markets agreed to end the restricted period with respect to certain shares subject to lock-up agreements for Coya Therapeutics Inc on May 22.
May 23, 2023 | 8:44 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Coya Therapeutics may experience increased trading activity and potential price fluctuations as Chardan Capital Markets ends the restricted period for certain shares.
The end of the restricted period for certain shares of Coya Therapeutics by Chardan Capital Markets may lead to increased trading activity and potential price fluctuations. However, it is uncertain how the market will react to this news, so the short-term impact on the stock price is neutral.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100